Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Market Cap	58.05M
Revenue (ttm)	33.42M
Net Income (ttm)	6.98M
Shares Out	18.00M
EPS (ttm)	0.39
PE Ratio	8.33
Forward PE	n/a
Dividend	0.06 (1.76%)
Ex-Dividend Date	Apr 30, 2025

Volume	14,001
Average Volume	2,313
Open	4.550
Previous Close	4.650
Day's Range	4.550 - 4.550
52-Week Range	3.550 - 4.750
Beta	-0.01
RSI	53.34
Earnings Date	Dec 29, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions. It also produces detergent, cos...

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Employees: 531
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: JPH

Financial Performance

In 2024, Jerusalem Pharmaceuticals's revenue was $39.82 million, an increase of 0.42% compared to the previous year's $39.65 million. Earnings were $5.04 million, a decrease of -27.58%.

Financial numbers in USD